» Articles » PMID: 37375849

Asiatic Acid Inhibits Nasopharyngeal Carcinoma Cell Viability and Migration Via Suppressing STAT3 and Claudin-1

Overview
Publisher MDPI
Specialty Chemistry
Date 2023 Jun 28
PMID 37375849
Authors
Affiliations
Soon will be listed here.
Abstract

Nasopharyngeal carcinoma (NPC) is a prevalent cancer in Southeast Asia, but effective treatment options remain limited, and chemotherapy has a high resistance rate. Asiatic acid (AA), a triterpenoid found in , has shown anticancer activity in various cancers. Therefore, this study aims to investigate the anticancer effects and mechanisms of AA in NPC cell lines. The effects of AA on NPC cytotoxicity, apoptosis, and migration were determined in TW-01 and SUNE5-8F NPC cell lines. Western blot analysis was performed to evaluate the protein expression levels affected by AA. The role of AA in proliferation and migration was investigated in STAT3 and claudin-1 knockdown cells. AA inhibited NPC cell viability and migration and induced cell death by increasing cleaved caspase-3 expression. Moreover, AA inhibited STAT3 phosphorylation and reduced claudin-1 expression in NPC cells. Although knockdown of STAT3 or claudin-1 slightly reduced cell viability, it did not enhance the anti-proliferative effect of AA. However, knockdown of STAT3 or claudin-1 increased the anti-migratory effect of AA in NPC cells. These results suggest that AA can be a promising candidate for drug development against NPC.

Citing Articles

Asiatic acid in anticancer effects: emerging roles and mechanisms.

Chen R, Zhang W, Zhang M, Liu W, Feng W, Zhang Y Front Pharmacol. 2025; 16:1545654.

PMID: 40066340 PMC: 11891365. DOI: 10.3389/fphar.2025.1545654.


Roles of small peptides encoded by non-coding RNAs in tumor invasion and migration.

Liu J, Chang X, Manji L, Xu Z, Xiao W Front Pharmacol. 2024; 15:1442196.

PMID: 39351098 PMC: 11439703. DOI: 10.3389/fphar.2024.1442196.


Asiatic acid mitigates testosterone-induced benign prostatic hyperplasia in rats via activation of PPAR-γ.

Kamal H, Almutairi B, Abdel-Naim A Naunyn Schmiedebergs Arch Pharmacol. 2024; 398(2):1991-2001.

PMID: 39222244 DOI: 10.1007/s00210-024-03405-z.


Unraveling the Impact of Six Pentacyclic Triterpenes Regulating Metabolic Pathways on Lung Carcinoma Cells.

Torres-Sanchez A, Torres G, Estrada S, Perez D, Garcia C, Milian M Pharmaceuticals (Basel). 2024; 17(6).

PMID: 38931361 PMC: 11206507. DOI: 10.3390/ph17060694.


Can Asiatic Acid from Be a Potential Remedy in Cancer Therapy?-A Review.

Wicinski M, Fajkiel-Madajczyk A, Kurant Z, Gajewska S, Kurant D, Kurant M Cancers (Basel). 2024; 16(7).

PMID: 38610995 PMC: 11011005. DOI: 10.3390/cancers16071317.


References
1.
Wang G, Jing Y, Cao L, Gong C, Gong Z, Cao X . A novel synthetic Asiatic acid derivative induces apoptosis and inhibits proliferation and mobility of gastric cancer cells by suppressing STAT3 signaling pathway. Onco Targets Ther. 2017; 10:55-66. PMC: 5189974. DOI: 10.2147/OTT.S121619. View

2.
Wang Z, Luo F, Li L, Yang L, Hu D, Ma X . STAT3 activation induced by Epstein-Barr virus latent membrane protein1 causes vascular endothelial growth factor expression and cellular invasiveness via JAK3 And ERK signaling. Eur J Cancer. 2010; 46(16):2996-3006. DOI: 10.1016/j.ejca.2010.07.008. View

3.
Lui V, Wong E, Ho Y, Hong B, Wong S, Tao Q . STAT3 activation contributes directly to Epstein-Barr virus-mediated invasiveness of nasopharyngeal cancer cells in vitro. Int J Cancer. 2009; 125(8):1884-93. DOI: 10.1002/ijc.24567. View

4.
de Jongh F, van Veen R, Veltman S, de Wit R, van der Burg M, van den Bent M . Weekly high-dose cisplatin is a feasible treatment option: analysis on prognostic factors for toxicity in 400 patients. Br J Cancer. 2003; 88(8):1199-206. PMC: 2747572. DOI: 10.1038/sj.bjc.6600884. View

5.
Wu X, Xiao J, Zhao C, Zhao C, Han Z, Wang F . Claudin1 promotes the proliferation, invasion and migration of nasopharyngeal carcinoma cells by upregulating the expression and nuclear entry of β-catenin. Exp Ther Med. 2018; 16(4):3445-3451. PMC: 6143911. DOI: 10.3892/etm.2018.6619. View